| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
10.42 |
% |
10.6019/CHEMBL4513149 |
| Bacillus anthracis |
Anthrax lethal factor |
Potency |
12589.3 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
19952.6 |
nM |
None |
| Bacillus subtilis (strain 168) |
DNA polymerase III |
Potency |
7519.3 |
nM |
None |
| Candida albicans |
Candida albicans |
Inhibition |
39.24 |
% |
10.6019/CHEMBL4513149 |
| Cavia porcellus |
Cavia porcellus |
ED50 |
603.0 |
ug ml-1 |
10.1021/jm00177a006 |
| Cavia porcellus |
Cavia porcellus |
Inhibition |
44.0 |
% |
10.1021/jm00177a006 |
| Chlorocebus sabaeus |
Vero |
IC50 |
nan |
None |
10.1016/j.bmc.2007.06.042 |
| Chlorocebus sabaeus |
Vero |
IC50 |
nan |
None |
10.1021/np049682k |
| Chlorocebus sabaeus |
Vero |
IC50 |
nan |
None |
10.1021/np0502600 |
| Chlorocebus sabaeus |
Vero |
IC50 |
nan |
None |
10.1021/np0702281 |
| Chlorocebus sabaeus |
Vero |
IC50 |
nan |
None |
10.1021/np300638f |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
2.45 |
% |
10.6019/CHEMBL4513149 |
| Dengue virus |
Dengue virus |
Kd |
40.0 |
nM |
10.1021/jm000412i |
| Dengue virus |
Dengue virus |
k_off |
0.04 |
s-1 |
10.1021/jm000412i |
| Dengue virus |
Dengue virus |
k_on |
1000000.0 |
M-1.s-1 |
10.1021/jm000412i |
| Emericella nidulans |
RmtA |
IC50 |
5900.0 |
nM |
10.1021/jm061213n |
| Escherichia coli |
Escherichia coli |
Inhibition |
7.96 |
% |
10.6019/CHEMBL4513149 |
| Homo sapiens |
786-0 |
GI50 |
74644.88 |
nM |
None |
| Homo sapiens |
A498 |
GI50 |
84333.48 |
nM |
None |
| Homo sapiens |
A549 |
GI50 |
56363.77 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
ACHN |
GI50 |
97949.0 |
nM |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
8565.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Arachidonate 15-lipoxygenase, type II |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
ATH-8 cell line |
MIC |
35000.0 |
nM |
10.1021/jm00159a001 |
| Homo sapiens |
ATH-8 cell line |
SI |
5.0 |
None |
10.1021/jm00159a001 |
| Homo sapiens |
ATP-dependent DNA helicase Q1 |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
ATP-dependent DNA helicase Q1 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
ATP-dependent DNA helicase Q1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Autotaxin |
Inhibition |
27.0 |
% |
10.1021/jm901718z |
| Homo sapiens |
Beta-glucocerebrosidase |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Breast cancer type 1 susceptibility protein |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
BT-549 |
GI50 |
95719.41 |
nM |
None |
| Homo sapiens |
CAKI-1 |
GI50 |
73451.39 |
nM |
None |
| Homo sapiens |
Cathepsin B |
IC50 |
30000.0 |
nM |
10.1021/jm070760l |
| Homo sapiens |
Cathepsin B |
Inhibition |
nan |
% |
10.1021/jm900629w |
| Homo sapiens |
Cathepsin B |
Ki |
nan |
None |
10.1021/jm900629w |
| Homo sapiens |
CCRF-CEM |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
1995.3 |
nM |
None |
| Homo sapiens |
COLO 205 |
GI50 |
72945.75 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
39810.72 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
nan |
None |
None |
| Homo sapiens |
DLD-1 |
GI50 |
97498.96 |
nM |
None |
| Homo sapiens |
DMS-114 |
GI50 |
28575.91 |
nM |
None |
| Homo sapiens |
DMS-273 |
GI50 |
39810.72 |
nM |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
DNA-dependent protein kinase |
IC50 |
1700.0 |
nM |
10.1021/jm020427b |
| Homo sapiens |
DNA polymerase iota |
Potency |
1122.0 |
nM |
None |
| Homo sapiens |
DNA polymerase kappa |
Potency |
31.6 |
nM |
None |
| Homo sapiens |
DNA polymerase kappa |
Potency |
89.1 |
nM |
None |
| Homo sapiens |
DNA polymerase kappa |
Potency |
266.8 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
DU-145 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Ectonucleoside triphosphate diphosphohydrolase 8 |
Ki |
100000.0 |
nM |
10.1021/jm800175e |
| Homo sapiens |
EKVX |
GI50 |
69502.43 |
nM |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
26482.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ferrochelatase, mitochondrial |
Inhibition |
nan |
% |
10.6019/CHEMBL3987221 |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
335.9 |
nM |
None |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
1258.9 |
nM |
None |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
2009.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glutaminase kidney isoform, mitochondrial |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
HCC 2998 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
HCT-116 |
GI50 |
76032.63 |
nM |
None |
| Homo sapiens |
HCT-116 |
IC50 |
nan |
ug.mL-1 |
10.1016/s0960-894x(02)00392-x |
| Homo sapiens |
HCT-116 |
Inhibition |
nan |
% |
10.1016/s0960-894x(02)00392-x |
| Homo sapiens |
HCT-15 |
GI50 |
90782.05 |
nM |
None |
| Homo sapiens |
HEK293 |
Activity |
nan |
None |
10.1016/j.bmcl.2012.03.030 |
| Homo sapiens |
HEK293 |
Potency |
4448.8 |
nM |
None |
| Homo sapiens |
HEK293 |
Potency |
8876.6 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
19040.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
2.21 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
32.32 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
281.8 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
1412.5 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase MLL |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
HL-60 |
GI50 |
49431.07 |
nM |
None |
| Homo sapiens |
Homo sapiens |
CL |
0.0011 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL |
0.0057 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL |
0.0057 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.0 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.0046 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fa |
0.0 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
F_fraction |
0.0 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fg |
1.0 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fh |
1.0 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
IC50 |
nan |
nM |
10.1016/j.bmcl.2004.05.026 |
| Homo sapiens |
Homo sapiens |
Inhibition |
nan |
% |
10.1016/j.bmcl.2004.05.026 |
| Homo sapiens |
Homo sapiens |
Vdss |
0.54 |
L.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
HOP-18 |
GI50 |
52360.04 |
nM |
None |
| Homo sapiens |
HOP-62 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
HOP-92 |
GI50 |
54450.27 |
nM |
None |
| Homo sapiens |
Hs-578T |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
HT-29 |
GI50 |
62373.48 |
nM |
None |
| Homo sapiens |
HT-29 |
IC50 |
nan |
None |
10.1016/j.bmcl.2015.05.015 |
| Homo sapiens |
HUVEC |
IC50 |
500000.0 |
nM |
10.1016/j.ejmech.2011.11.040 |
| Homo sapiens |
HUVEC |
IC50 |
500000.0 |
nM |
10.1016/s0960-894x(01)00535-2 |
| Homo sapiens |
IGROV-1 |
GI50 |
69342.58 |
nM |
None |
| Homo sapiens |
K562 |
GI50 |
93540.57 |
nM |
None |
| Homo sapiens |
K562 |
IC50 |
18490.0 |
nM |
10.1016/j.bmcl.2012.03.030 |
| Homo sapiens |
KM12 |
GI50 |
67452.8 |
nM |
None |
| Homo sapiens |
KM-20L2 |
GI50 |
34593.94 |
nM |
None |
| Homo sapiens |
LOX IMVI |
GI50 |
51050.5 |
nM |
None |
| Homo sapiens |
LXFL 529 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
M14 |
GI50 |
74816.95 |
nM |
None |
| Homo sapiens |
M19-MEL |
GI50 |
59703.53 |
nM |
None |
| Homo sapiens |
Malme-3M |
GI50 |
82985.08 |
nM |
None |
| Homo sapiens |
MCF7 |
GI |
32.0 |
% |
10.1016/j.bmcl.2012.08.017 |
| Homo sapiens |
MCF7 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
MCF7 |
IC50 |
nan |
None |
10.1016/j.bmcl.2015.05.015 |
| Homo sapiens |
MDA-MB-231 |
GI |
26.0 |
% |
10.1016/j.bmcl.2012.08.017 |
| Homo sapiens |
MDA-MB-231 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
MDA-MB-231 |
IC50 |
31190.0 |
nM |
10.1016/j.bmcl.2012.03.030 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
nan |
None |
10.1016/j.bmcl.2015.05.015 |
| Homo sapiens |
MDA-MB-435 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
MDA-N |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
MOLT-4 |
GI50 |
79983.43 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
M-phase phosphoprotein 8 |
Potency |
1888.8 |
nM |
None |
| Homo sapiens |
MRC5 |
IC50 |
100.0 |
ug.mL-1 |
10.1016/j.bmc.2008.10.061 |
| Homo sapiens |
MRC5 |
IC50 |
100.0 |
ug.mL-1 |
10.1016/j.bmcl.2013.12.052 |
| Homo sapiens |
MRC5 |
IC50 |
nan |
nM |
10.1016/j.bmcl.2004.05.026 |
| Homo sapiens |
MT4 |
CC50 |
47000.0 |
nM |
10.1021/jm00066a008 |
| Homo sapiens |
MT4 |
CC50 |
250000.0 |
nM |
10.1021/jm00104a010 |
| Homo sapiens |
MT4 |
EC50 |
8000.0 |
nM |
10.1021/jm00066a008 |
| Homo sapiens |
MT4 |
EC50 |
8200.0 |
nM |
10.1021/jm00104a010 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 1 |
Activity |
18.0 |
% |
10.1016/j.ejmech.2012.07.001 |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 1 |
IC50 |
300.0 |
nM |
10.1021/jm400204k |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 1 |
IC50 |
300.0 |
nM |
10.1021/ml3002709 |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 1 |
IC50 |
300.0 |
nM |
10.1039/C0MD00062K |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 1 |
IC50 |
600.0 |
nM |
10.1016/j.bmc.2009.07.073 |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 1 |
IC50 |
2600.0 |
nM |
10.1016/j.bmcl.2012.08.017 |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 1 |
IC50 |
2620.0 |
nM |
None |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 1 |
IC50 |
2800.0 |
nM |
10.1016/j.bmcl.2012.03.030 |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 1 |
IC50 |
2800.0 |
nM |
10.1016/j.bmcl.2015.05.015 |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 1 |
Inhibition |
53.9 |
% |
10.1016/j.bmcl.2012.03.030 |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 1 |
Inhibition |
79.0 |
% |
10.1016/j.bmcl.2012.06.003 |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 1 |
Inhibition |
82.3 |
% |
10.1016/j.bmcl.2012.08.017 |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 1 |
Inhibition |
nan |
% |
10.1016/j.bmc.2010.12.026 |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 2 |
Activity |
20.0 |
% |
10.1016/j.ejmech.2012.07.001 |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 2 |
IC50 |
1100.0 |
nM |
10.1021/ml3002709 |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 2 |
IC50 |
1200.0 |
nM |
10.1021/jm400204k |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 3 |
Activity |
nan |
None |
10.1016/j.ejmech.2012.07.001 |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 3 |
IC50 |
nan |
None |
10.1021/ml3002709 |
| Homo sapiens |
NAD-dependent deacetylase sirtuin 3 |
Inhibition |
nan |
% |
10.1016/j.ejmech.2012.07.001 |
| Homo sapiens |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
IC50 |
2000.0 |
nM |
10.1016/j.bmcl.2015.03.018 |
| Homo sapiens |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
IC50 |
3000.0 |
nM |
10.1016/j.bmcl.2015.03.018 |
| Homo sapiens |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
IC50 |
14200.0 |
nM |
10.1016/j.bmcl.2012.10.136 |
| Homo sapiens |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
IC50 |
22000.0 |
nM |
10.1016/j.bmcl.2015.03.018 |
| Homo sapiens |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
IC50 |
25000.0 |
nM |
10.1016/j.bmcl.2015.03.018 |
| Homo sapiens |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
IC50 |
25000.0 |
nM |
10.1021/ml3002709 |
| Homo sapiens |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
IC50 |
27000.0 |
nM |
10.1021/jm300526r |
| Homo sapiens |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
IC50 |
46600.0 |
nM |
10.1021/ml3002709 |
| Homo sapiens |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
Inhibition |
20.0 |
% |
10.1016/j.bmcl.2012.10.136 |
| Homo sapiens |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
Inhibition |
nan |
% |
10.1016/j.bmcl.2012.10.136 |
| Homo sapiens |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
Inhibition |
nan |
% |
10.1016/j.bmcl.2015.03.018 |
| Homo sapiens |
NCI/ADR-RES |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
NCI-H226 |
GI50 |
63826.35 |
nM |
None |
| Homo sapiens |
NCI-H23 |
GI50 |
68865.23 |
nM |
None |
| Homo sapiens |
NCI-H322M |
GI50 |
61376.2 |
nM |
None |
| Homo sapiens |
NCI-H460 |
GI50 |
80537.84 |
nM |
None |
| Homo sapiens |
NCI-H522 |
GI50 |
88511.56 |
nM |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
4109.5 |
nM |
None |
| Homo sapiens |
OVCAR-3 |
GI50 |
93325.43 |
nM |
None |
| Homo sapiens |
OVCAR-4 |
GI50 |
79250.13 |
nM |
None |
| Homo sapiens |
OVCAR-5 |
GI50 |
50582.47 |
nM |
None |
| Homo sapiens |
OVCAR-8 |
GI50 |
74816.95 |
nM |
None |
| Homo sapiens |
P2X purinoceptor 3 |
EC50 |
3000.0 |
nM |
10.1021/jm020046y |
| Homo sapiens |
P2X purinoceptor 3 |
EC50 |
14900.0 |
nM |
10.1021/jm020046y |
| Homo sapiens |
P2X purinoceptor 7 |
EC50 |
92000.0 |
nM |
10.1021/jm020046y |
| Homo sapiens |
PC-3 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
PC-3 |
IC50 |
nan |
nM |
10.1021/jm0304461 |
| Homo sapiens |
PC-3 |
IC50 |
nan |
None |
10.1021/np0502600 |
| Homo sapiens |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 |
Potency |
425.6 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Plasma |
PPB |
99.4 |
% |
10.1128/aac.00372-07 |
| Homo sapiens |
Porphobilinogen deaminase |
Inhibition |
nan |
% |
10.6019/CHEMBL3987221 |
| Homo sapiens |
Pregnane X receptor |
Activity |
nan |
None |
10.1124/dmd.110.035105 |
| Homo sapiens |
Pregnane X receptor |
EC50 |
1300.0 |
nM |
10.1124/dmd.110.035105 |
| Homo sapiens |
Pregnane X receptor |
Efficacy |
66.0 |
% |
10.1124/dmd.110.035105 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein-arginine N-methyltransferase 1 |
IC50 |
5330.0 |
nM |
10.1021/jm100416n |
| Homo sapiens |
Protein-arginine N-methyltransferase 1 |
IC50 |
18100.0 |
nM |
10.1021/jm061213n |
| Homo sapiens |
Protein-arginine N-methyltransferase 1 |
IC50 |
1011000.0 |
nM |
10.1021/jm100416n |
| Homo sapiens |
Protein kinase C (PKC) |
IC50 |
29000.0 |
nM |
10.1021/jm020427b |
| Homo sapiens |
Protein-tyrosine phosphatase 1B |
Inhibition |
20.0 |
% |
10.1007/s00044-012-0007-0 |
| Homo sapiens |
Protein-tyrosine phosphatase 1B |
Inhibition |
20.0 |
% |
10.1007/s00044-012-0165-0 |
| Homo sapiens |
Protein-tyrosine phosphatase 1B |
Inhibition |
60.0 |
% |
10.1039/C3MD00138E |
| Homo sapiens |
Purinergic receptor P2Y1 |
Inhibition |
54.5 |
% |
10.1021/jm050301p |
| Homo sapiens |
Purinergic receptor P2Y1 |
Inhibition |
59.3 |
% |
10.1021/jm050301p |
| Homo sapiens |
Purinergic receptor P2Y11 |
EC50 |
16000.0 |
nM |
10.1021/jm020046y |
| Homo sapiens |
Purinergic receptor P2Y11 |
Inhibition |
89.5 |
% |
10.1021/jm050301p |
| Homo sapiens |
Purinergic receptor P2Y11 |
Inhibition |
93.7 |
% |
10.1021/jm050301p |
| Homo sapiens |
Purinergic receptor P2Y11 |
Ki |
112.2 |
nM |
10.1021/jm050301p |
| Homo sapiens |
Purinergic receptor P2Y11 |
Ki |
302.0 |
nM |
10.1021/jm050301p |
| Homo sapiens |
Purinergic receptor P2Y11 |
Rel potency |
15.0 |
None |
10.1021/jm050301p |
| Homo sapiens |
Purinergic receptor P2Y11 |
Rel potency |
40.0 |
None |
10.1021/jm050301p |
| Homo sapiens |
Purinergic receptor P2Y2 |
EC50 |
48000.0 |
nM |
10.1021/jm020046y |
| Homo sapiens |
Purinergic receptor P2Y2 |
IC50 |
50000.0 |
nM |
10.1021/jm800175e |
| Homo sapiens |
Purinergic receptor P2Y2 |
Inhibition |
31.6 |
% |
10.1021/jm050301p |
| Homo sapiens |
Purinergic receptor P2Y2 |
Inhibition |
50.5 |
% |
10.1021/jm050301p |
| Homo sapiens |
Pyrimidinergic receptor P2Y4 |
Activity |
nan |
None |
10.1021/jm800175e |
| Homo sapiens |
Pyrimidinergic receptor P2Y4 |
EC50 |
100000.0 |
nM |
10.1021/jm020046y |
| Homo sapiens |
Pyrimidinergic receptor P2Y6 |
IC50 |
27000.0 |
nM |
10.1021/jm800175e |
| Homo sapiens |
Pyrimidinergic receptor P2Y6 |
Inhibition |
27.0 |
% |
10.1021/jm020046y |
| Homo sapiens |
Pyruvate kinase isozymes M1/M2 |
IC50 |
20000.0 |
nM |
10.1039/D1MD00045D |
| Homo sapiens |
Pyruvate kinase isozymes M1/M2 |
IC50 |
33000.0 |
nM |
10.1039/D1MD00045D |
| Homo sapiens |
Pyruvate kinase isozymes M1/M2 |
Ki |
10000.0 |
nM |
10.1039/D1MD00045D |
| Homo sapiens |
Pyruvate kinase isozymes M1/M2 |
Ki |
16500.0 |
nM |
10.1039/D1MD00045D |
| Homo sapiens |
Pyruvate kinase isozymes R/L |
IC50 |
2200.0 |
nM |
10.1039/D1MD00045D |
| Homo sapiens |
Pyruvate kinase isozymes R/L |
Ki |
1100.0 |
nM |
10.1039/D1MD00045D |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
7.5 |
nM |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
37685.8 |
nM |
None |
| Homo sapiens |
RPMI-8226 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Runt-related transcription factor 1/Core-binding factor subunit beta |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
RXF 393 |
GI50 |
92682.98 |
nM |
None |
| Homo sapiens |
RXF 631 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
9130.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
SF-268 |
GI50 |
66221.65 |
nM |
None |
| Homo sapiens |
SF-295 |
GI50 |
69023.98 |
nM |
None |
| Homo sapiens |
SF-539 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SK-MEL-2 |
GI50 |
58884.37 |
nM |
None |
| Homo sapiens |
SK-MEL-28 |
GI50 |
91622.05 |
nM |
None |
| Homo sapiens |
SK-MEL-5 |
GI50 |
84722.74 |
nM |
None |
| Homo sapiens |
SK-OV-3 |
GI50 |
88104.89 |
nM |
None |
| Homo sapiens |
SN12C |
GI50 |
80909.59 |
nM |
None |
| Homo sapiens |
SNB-19 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SNB-75 |
GI50 |
48194.78 |
nM |
None |
| Homo sapiens |
SNB-78 |
GI50 |
71285.3 |
nM |
None |
| Homo sapiens |
SR |
GI50 |
69342.58 |
nM |
None |
| Homo sapiens |
SW-620 |
GI50 |
89330.55 |
nM |
None |
| Homo sapiens |
T47D |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
TK-10 |
GI50 |
31988.95 |
nM |
None |
| Homo sapiens |
Tumor susceptibility gene 101 protein |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
891.3 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
4466.8 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
U-251 |
GI50 |
77268.06 |
nM |
None |
| Homo sapiens |
UACC-257 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
UACC-62 |
GI50 |
54575.79 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 2 |
Potency |
3288.5 |
nM |
None |
| Homo sapiens |
UO-31 |
GI50 |
39355.01 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
1551.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vitamin D receptor |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Vitamin D receptor |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Vitamin D receptor |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
WI-38 |
IC50 |
nan |
None |
10.1016/j.ejmech.2013.06.004 |
| Homo sapiens |
XF498 |
GI50 |
26977.39 |
nM |
None |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 protease |
Inhibition |
83.0 |
% |
10.1021/jm00105a033 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 reverse transcriptase |
IC50 |
18.0 |
ug.mL-1 |
10.1021/np50073a012 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 reverse transcriptase |
IC50 |
18.0 |
ug.mL-1 |
10.1021/np9700275 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 reverse transcriptase |
IC50 |
9400.0 |
nM |
10.1021/jm00104a010 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 reverse transcriptase |
IC50 |
15000.0 |
nM |
10.1021/jm00104a010 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 reverse transcriptase |
ID50 |
42.0 |
ug ml-1 |
10.1021/jm00105a033 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 reverse transcriptase |
Inhibition |
18.0 |
% |
10.1021/jm00105a033 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 reverse transcriptase |
Inhibition |
22.0 |
% |
10.1021/jm00105a033 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 reverse transcriptase |
Inhibition |
92.0 |
% |
10.1021/jm00105a033 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
17.11 |
% |
10.6019/CHEMBL4513149 |
| Leishmania amazonensis |
Leishmania amazonensis |
IC50 |
nan |
nM |
10.1016/j.bmcl.2004.05.026 |
| Leishmania donovani |
Leishmania donovani |
Activity |
nan |
None |
10.1021/np0702281 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
nan |
nM |
10.1021/jm0304461 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
nan |
None |
10.1016/j.bmc.2007.06.042 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
nan |
None |
10.1021/np049682k |
| Leishmania donovani |
Leishmania donovani |
IC50 |
nan |
None |
10.1021/np0502600 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
nan |
None |
10.1021/np0702281 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
nan |
None |
10.1021/np300638f |
| Leishmania donovani |
Leishmania donovani |
Inhibition |
nan |
% |
10.1021/np0702281 |
| Leishmania infantum |
Leishmania infantum |
IC50 |
nan |
nM |
10.1016/j.bmcl.2004.05.026 |
| Leishmania mexicana mexicana |
Leishmania mexicana mexicana |
IC50 |
nan |
None |
10.1016/j.ejmech.2013.06.004 |
| Litomosoides carinii |
Litomosoides carinii |
Reduction |
71.0 |
% |
10.1021/jm00373a017 |
| Litomosoides carinii |
Litomosoides carinii |
Reduction of live worms |
98.0 |
% |
10.1021/jm00363a010 |
| Meleagris gallopavo |
P2Y purinoceptor 1 |
EC50 |
10000.0 |
nM |
10.1021/jm020046y |
| Mus musculus |
B16 |
IC50 |
nan |
ug.mL-1 |
10.1016/s0960-894x(02)00392-x |
| Mus musculus |
B16 |
Inhibition |
nan |
% |
10.1016/s0960-894x(02)00392-x |
| Mus musculus |
J774 |
IC50 |
nan |
nM |
10.1021/jm0304461 |
| Mus musculus |
J774 |
IC50 |
nan |
None |
10.1021/np070038q |
| Mus musculus |
J774.A1 |
IC50 |
nan |
None |
10.1021/np049682k |
| Mus musculus |
Mus musculus |
Activity |
25.5 |
g |
10.1016/j.ejmech.2011.11.040 |
| Mus musculus |
Plasma |
PPB |
97.0 |
% |
10.1128/aac.00372-07 |
| Naegleria gruberi |
Naegleria gruberi |
Inhibition |
32.0 |
% |
10.6019/CHEMBL4513101 |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Potency |
11423.9 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
nan |
nM |
10.1016/j.bmcl.2004.05.026 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
nan |
None |
10.1016/j.bmcl.2006.07.057 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
nan |
None |
10.1016/j.ejmech.2013.06.004 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
nan |
None |
10.1016/j.ejmech.2015.05.044 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
nan |
None |
10.1021/jm900946n |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
nan |
None |
10.1021/np300638f |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
15.45 |
% |
10.6019/CHEMBL4513149 |
| Rattus norvegicus |
Ectonucleoside triphosphate diphosphohydrolase 1 |
Ki |
300000.0 |
nM |
10.1016/j.bmcl.2006.09.003 |
| Rattus norvegicus |
Ectonucleoside triphosphate diphosphohydrolase 1 |
Ki |
300000.0 |
nM |
10.1021/jm800175e |
| Rattus norvegicus |
Ectonucleoside triphosphate diphosphohydrolase 2 |
Ki |
65400.0 |
nM |
10.1016/j.bmcl.2006.09.003 |
| Rattus norvegicus |
Ectonucleoside triphosphate diphosphohydrolase 2 |
Ki |
65400.0 |
nM |
10.1021/jm800175e |
| Rattus norvegicus |
Inositol monophosphatase 1 |
Potency |
3162.3 |
nM |
None |
| Rattus norvegicus |
L6 |
IC50 |
4724500.0 |
nM |
10.1016/j.bmcl.2006.07.057 |
| Rattus norvegicus |
L6 |
IC50 |
4725000.0 |
nM |
10.1016/j.bmcl.2015.02.044 |
| Rattus norvegicus |
L6 |
IC50 |
nan |
None |
10.1016/j.bmc.2010.11.003 |
| Rattus norvegicus |
Nuclear receptor subfamily 1 group I member 2 |
Activity |
nan |
None |
10.1124/dmd.110.035105 |
| Rattus norvegicus |
Nucleoside triphosphate diphosphohydrolase 3 |
Ki |
12700.0 |
nM |
10.1016/j.bmcl.2006.09.003 |
| Rattus norvegicus |
P2X purinoceptor 1 |
EC50 |
1000.0 |
nM |
10.1021/jm020046y |
| Rattus norvegicus |
P2X purinoceptor 2 |
EC50 |
10400.0 |
nM |
10.1021/jm020046y |
| Rattus norvegicus |
P2X purinoceptor 2 |
IC50 |
4000.0 |
nM |
10.1021/jm1012193 |
| Rattus norvegicus |
P2X purinoceptor 2 |
IC50 |
39810.72 |
nM |
10.1021/jm1012193 |
| Rattus norvegicus |
P2X purinoceptor 4 |
EC50 |
100000.0 |
nM |
10.1021/jm020046y |
| Rattus norvegicus |
P2X purinoceptor 5 |
EC50 |
4000.0 |
nM |
10.1021/jm020046y |
| Rattus norvegicus |
P2X purinoceptor 6 |
EC50 |
100000.0 |
nM |
10.1021/jm020046y |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
36125.4 |
nM |
None |
| Rattus norvegicus |
Plasma |
Fu |
0.003 |
None |
10.1021/jm901371v |
| Rattus norvegicus |
Purinergic receptor P2Y12 |
EC50 |
4000.0 |
nM |
10.1021/jm020046y |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1021/jm00135a003 |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
14125.4 |
nM |
None |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Potency |
16360.1 |
nM |
None |
| Saccharomyces cerevisiae S288c |
NAD-dependent deacetylase HST2 |
IC50 |
240000.0 |
nM |
10.1016/j.bmc.2009.07.073 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
IC50 |
260.0 |
nM |
10.1016/j.bmc.2023.117179 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
23.13 |
% |
10.6019/CHEMBL4513149 |
| Staphylococcus aureus (strain NCTC 8325) |
ATP-dependent Clp protease proteolytic subunit |
Inhibition |
50.0 |
% |
10.1021/acs.jmedchem.9b01746 |
| Sus scrofa |
Tubulin |
IC50 |
nan |
None |
10.1016/j.bmc.2007.06.042 |
| Trypanosoma brucei |
6-phospho-1-fructokinase |
IC50 |
3000.0 |
nM |
10.1021/ml400259d |
| Trypanosoma brucei |
6-phospho-1-fructokinase |
Potency |
674.6 |
nM |
None |
| Trypanosoma brucei |
6-phospho-1-fructokinase |
Potency |
7079.5 |
nM |
None |
| Trypanosoma brucei |
Trypanosoma brucei |
EC50 |
20.0 |
nM |
10.1021/jm021030a |
| Trypanosoma brucei |
Trypanosoma brucei |
EC50 |
40.0 |
nM |
10.1021/acs.jmedchem.5b00515 |
| Trypanosoma brucei |
Trypanosoma brucei |
IC50 |
110.0 |
nM |
10.1016/j.bmc.2010.11.003 |
| Trypanosoma brucei |
Trypanosoma brucei |
IC50 |
130.0 |
nM |
10.1021/jm070760l |
| Trypanosoma brucei |
Trypanosoma brucei |
IC50 |
210.0 |
nM |
10.1021/jm0304461 |
| Trypanosoma brucei |
Trypanosoma brucei |
IC50 |
900.0 |
nM |
10.1016/j.bmcl.2004.05.026 |
| Trypanosoma brucei |
Trypanosoma brucei |
IC50 |
1400.0 |
nM |
10.1021/np300834q |
| Trypanosoma brucei |
Trypanosoma brucei |
MEC |
0.8 |
uM |
10.1021/jm021030a |
| Trypanosoma brucei brucei |
Phosphoglycerate kinase, glycosomal |
Potency |
2685.5 |
nM |
None |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
Activity |
nan |
None |
10.1016/j.bmc.2014.08.005 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
ED50 |
0.3 |
uM |
10.1021/jm070763y |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
ED50 |
130.0 |
nM |
10.1021/jm301424d |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
GI |
nan |
None |
10.1021/acs.jmedchem.5b00687 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
0.11 |
ug.mL-1 |
10.1016/j.ejmech.2013.06.004 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
0.193 |
ug.mL-1 |
10.1021/np049682k |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
1.58 |
ug.mL-1 |
10.1016/j.bmc.2008.10.061 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
1.58 |
ug.mL-1 |
10.1016/j.bmcl.2013.12.052 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
5.0 |
nM |
10.1016/j.ejmech.2014.04.079 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
5.0 |
nM |
10.1021/jm101225g |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
20.0 |
nM |
10.1016/j.bmc.2014.08.005 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
30.0 |
nM |
10.1016/j.ejmech.2015.05.044 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
41.0 |
nM |
10.1021/np070038q |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
77.0 |
nM |
10.1016/j.bmc.2007.06.042 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
130.0 |
nM |
10.1021/np300638f |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
190.0 |
nM |
10.1021/np0502600 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
200.0 |
nM |
10.1021/np0702281 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
250.0 |
nM |
10.1016/j.bmcl.2011.01.101 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
310.0 |
nM |
10.1021/jm900629w |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
310.0 |
nM |
10.1021/np5006554 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
Inhibition |
100.0 |
% |
10.1016/j.bmc.2014.08.005 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
MIC |
60.0 |
nM |
10.1016/j.bmc.2010.11.012 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
MST |
21.0 |
day |
10.1016/j.bmc.2014.08.005 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
Survival |
100.0 |
% |
10.1016/j.ejmech.2014.04.079 |
| Trypanosoma brucei rhodesiense |
Rhodesain |
Inhibition |
32.0 |
% |
10.1021/jm900629w |
| Trypanosoma brucei rhodesiense |
Rhodesain |
Inhibition |
nan |
% |
10.1021/jm900629w |
| Trypanosoma brucei rhodesiense |
Rhodesain |
Ki |
nan |
None |
10.1021/jm900629w |
| Trypanosoma brucei rhodesiense |
Rhodesain |
Ki |
nan |
None |
10.1021/jm900946n |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
EC50 |
185.3 |
nM |
10.1016/j.bmcl.2011.10.108 |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
0.13 |
ug.mL-1 |
10.1016/j.bmc.2009.01.011 |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
7.5 |
nM |
10.1016/j.bmcl.2006.07.057 |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
7.5 |
nM |
10.1016/j.bmcl.2015.02.044 |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
20.0 |
nM |
10.1016/j.bmc.2014.08.005 |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
120.0 |
nM |
10.1016/j.bmc.2010.11.003 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
nan |
nM |
10.1016/j.bmcl.2004.05.026 |
| Trypanosoma evansi |
Trypanosoma evansi |
Activity |
nan |
None |
10.1128/aac.00422-09 |
| Trypanosoma evansi |
Trypanosoma evansi |
Survival |
11.0 |
day |
10.1128/aac.00422-09 |
| Trypanosoma evansi |
Trypanosoma evansi |
Survival |
51.0 |
day |
10.1128/aac.00422-09 |
| Trypanosoma evansi |
Trypanosoma evansi |
Survival |
60.0 |
day |
10.1128/aac.00422-09 |
| None |
ADMET |
CL |
0.0057 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Drug uptake |
6.7 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
7.4 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
8.6 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
9.5 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
10.9 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
11.4 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
12.5 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
13.0 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
25.3 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
26.6 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
27.2 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
29.3 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
39.0 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
46.0 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
57.0 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
97.0 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
99.4 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
100.0 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
163.0 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
263.0 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
388.0 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
Drug uptake |
437.0 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
IC50 |
64000.0 |
nM |
10.1016/j.bmc.2014.08.005 |
| None |
ADMET |
IC50 |
nan |
None |
10.1016/j.ejmech.2015.05.044 |
| None |
ADMET |
MRT |
1400.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
PPB |
95.3 |
% |
10.1128/aac.00372-07 |
| None |
ADMET |
T1/2 |
1200.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
0.54 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Molecular identity unknown |
ED50 |
167.0 |
ug ml-1 |
10.1021/jm00177a006 |
| None |
NON-PROTEIN TARGET |
Activity |
2.0 |
None |
10.1021/jm00395a010 |
| None |
NON-PROTEIN TARGET |
Activity |
5.0 |
None |
10.1016/j.ejmech.2011.11.040 |
| None |
NON-PROTEIN TARGET |
Activity |
5.9 |
g |
10.1016/j.ejmech.2011.11.040 |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1021/jm00395a010 |
| None |
NON-PROTEIN TARGET |
Fu |
0.001 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
6.3 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
11.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
63.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Potency |
10583.9 |
nM |
None |
| None |
No relevant target |
LogD |
0.00023 |
None |
10.1128/aac.00372-07 |
| None |
No relevant target |
Stability |
nan |
% |
10.1016/j.bmcl.2006.09.003 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1021/ci6004542 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1021/mp100103e |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1080/15376510701857262 |
| None |
Unchecked |
Ac50 |
6.31 |
uM |
None |
| None |
Unchecked |
Ac50 |
19.95 |
uM |
None |
| None |
Unchecked |
Ac50 |
39.81 |
uM |
None |
| None |
Unchecked |
AC50 |
6309.6 |
nM |
None |
| None |
Unchecked |
AC50 |
19952.6 |
nM |
None |
| None |
Unchecked |
AC50 |
39810.7 |
nM |
None |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.bmcl.2007.04.013 |
| None |
Unchecked |
EC50 |
500000.0 |
nM |
10.1021/jm00395a010 |
| None |
Unchecked |
EC90 |
500.0 |
uM |
10.1021/jm00395a010 |
| None |
Unchecked |
ED50 |
21.0 |
ug ml-1 |
10.1021/jm00177a006 |
| None |
Unchecked |
ED50 |
50.0 |
ug ml-1 |
10.1021/jm00177a006 |
| None |
Unchecked |
Hepatotoxicity (acute) |
3.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
700.0 |
nM |
10.1021/jm900652e |
| None |
Unchecked |
IC50 |
2000.0 |
nM |
10.1016/j.bmcl.2007.04.013 |
| None |
Unchecked |
IC50 |
40000.0 |
nM |
None |
| None |
Unchecked |
IC50 |
400000.0 |
nM |
10.1021/jm020427b |
| None |
Unchecked |
IC50 |
nan |
None |
10.1016/j.bmc.2007.06.042 |
| None |
Unchecked |
ID100 |
7e-06 |
M |
10.1021/jm000412i |
| None |
Unchecked |
ID50 |
7e-07 |
M |
10.1021/jm000412i |
| None |
Unchecked |
Inhibition |
10.0 |
% |
10.1016/j.bmc.2010.09.041 |
| None |
Unchecked |
Ki |
12700.0 |
nM |
10.1021/jm800175e |
| None |
Unchecked |
Ki |
nan |
None |
10.1021/jm900946n |
| None |
Unchecked |
Potency |
2511.9 |
nM |
None |
| None |
Unchecked |
Potency |
3061.2 |
nM |
None |
| None |
Unchecked |
Potency |
3149.5 |
nM |
None |
| None |
Unchecked |
Potency |
4448.8 |
nM |
None |
| None |
Unchecked |
Potency |
5623.4 |
nM |
None |
| None |
Unchecked |
Potency |
6284.1 |
nM |
None |
| None |
Unchecked |
Potency |
8947.4 |
nM |
None |
| None |
Unchecked |
Potency |
11220.2 |
nM |
None |
| None |
Unchecked |
Potency |
11264.1 |
nM |
None |
| None |
Unchecked |
Potency |
17782.8 |
nM |
None |
| None |
Unchecked |
Potency |
28183.8 |
nM |
None |
| None |
Unchecked |
Potency |
35338.3 |
nM |
None |
| None |
Unchecked |
Potency |
158489.3 |
nM |
None |
| None |
Unchecked |
Ratio ED50 |
1900.0 |
None |
10.1021/jm301424d |
| None |
Unchecked |
Ratio IC50 |
63.0 |
None |
10.1016/j.bmc.2008.10.061 |
| None |
Unchecked |
Ratio IC50 |
63.0 |
None |
10.1016/j.bmcl.2013.12.052 |
| None |
Unchecked |
Ratio IC50 |
629900.0 |
None |
10.1016/j.bmcl.2015.02.044 |
| None |
Unchecked |
Ratio IC50 |
629933.0 |
None |
10.1016/j.bmcl.2006.07.057 |
| None |
Unchecked |
Ratio IC50 |
nan |
None |
10.1016/j.ejmech.2013.06.004 |
| None |
Unchecked |
Ratio IC50 |
nan |
None |
10.1016/j.ejmech.2015.05.044 |